Galindo-Murillo Rodrigo, Cohen Jack S, Akabayov Barak
Medicinal Chemistry Department, Skaggs Pharmacy Institute, University of Utah, Salt Lake City, UT, USA.
Department of Chemistry, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Mol Ther Nucleic Acids. 2020 Dec 3;23:527-535. doi: 10.1016/j.omtn.2020.11.023. eCollection 2021 Mar 5.
For antisense applications, oligonucleotides must be chemically modified to be resistant to endogenous nucleases. Until now, antisense oligonucleotide (ASO) analogs have been synthesized and then tested for their ability to duplex with a target nucleic acid, usually RNA. In this work, using molecular dynamics calculations simulations, we systematically tested a series of chemically modified analogs in which the 2-deoxyribose was substituted for by one or two methylene groups on each side of the phosphate backbone, producing four compounds, of which three were previously unknown. We used a 9-mer sequence of which the solution structure has been determined by NMR spectroscopy and tested the ability to form stable duplexes of these acyclic analogs to both DNA and RNA. In only one case out of eight, we unexpectedly found the formation of a stable duplex with complementary RNA. We also applied limitations on end fraying because of the terminal AT base pairs, in order to eliminate this as a factor in the comparative results. We consider this a predictive method to potentially identify target ASO analogs for synthesis and testing for antisense drug development.
对于反义应用,寡核苷酸必须进行化学修饰以抵抗内源性核酸酶。到目前为止,反义寡核苷酸(ASO)类似物已被合成,然后测试它们与靶核酸(通常是RNA)形成双链体的能力。在这项工作中,我们使用分子动力学计算模拟,系统地测试了一系列化学修饰的类似物,其中在磷酸主链的每一侧,2-脱氧核糖被一个或两个亚甲基取代,产生了四种化合物,其中三种是以前未知的。我们使用了一个9聚体序列,其溶液结构已通过核磁共振光谱确定,并测试了这些无环类似物与DNA和RNA形成稳定双链体的能力。在八个案例中只有一个案例,我们意外地发现与互补RNA形成了稳定的双链体。由于末端的AT碱基对,我们还对末端磨损施加了限制,以便消除这一因素对比较结果的影响。我们认为这是一种预测方法,有可能识别用于反义药物开发的合成和测试的靶标ASO类似物。